Mortimer Ian

PRESIDENT & CEO at XENE

Sold, on record
$24.8M
Dollars the filings state
Form 4 sales
8
Latest Mar 13, 2026
Form 144 notices
9
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • XENEXenon Pharmaceuticals Inc.PRESIDENT & CEO

Sales by reason

3
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice XENENotice
    Dec 1, 2025 2025

    Filed to sell 97 shares ($4k)

    Mortimer Ian, Officer, Director

    10b5-1 plan0x usual sizeFiling

  2. 2 Form 144 notice XENENotice
    Dec 5, 2025 +4 days

    Filed to sell 14,375 shares ($647k)

    Mortimer Ian, Officer, Director

    10b5-1 plan0.6x usual sizeFiling

  3. 3 Form 144 notice XENENotice
    Dec 8, 2025 +3 days

    Filed to sell 10,830 shares ($495k)

    Mortimer Ian, Officer, Director

    10b5-1 plan0.4x usual sizeFiling

  4. 4 Form 4 sale XENERoutine
    Dec 8, 2025 same day

    Sold 25,205 shares at $45.33 ($1.1M)

    Mortimer Ian, PRESIDENT & CEO

    10b5-1 planSold 80.8% of holdings ($1.4M position)6,000 shares left1x usual sizeFollows a Form 144Filing

  5. 5 Form 4 sale XENERoutine
    Jan 2, 2026 +25 days

    Sold 40,000 shares at $44.43 ($1.8M)

    Mortimer Ian, PRESIDENT & CEO

    10b5-1 planSold 87% of holdings ($2M position)6,000 shares left1.6x usual sizeFollows a Form 144Filing

  6. 6 Form 144 notice XENENotice
    Jan 2, 2026 same day

    Filed to sell 40,000 shares ($1.8M)

    Mortimer Ian, Officer, Director

    10b5-1 plan1.6x usual sizeFiling

  7. 7 Form 4 sale XENEUnusual
    Mar 10, 2026 +67 days

    Sold 281,269 shares at $60.32 ($17M)

    Mortimer Ian, PRESIDENT & CEO

    10b5-1 planSold 95% of holdings ($17.9M position)14,731 shares left11.2x usual sizeFiling

  8. 8 Form 4 sale XENERoutine
    Mar 13, 2026 +3 days

    Sold 7,308 shares at $55.23 ($404k)

    Mortimer Ian, PRESIDENT & CEO

    10b5-1 planSold 26.8% of holdings ($1.5M position)19,923 shares left0.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (17)

Form 144 notices and Form 4 sales by Mortimer Ian
Source
Mar 13, 2026Mar 13, 2026XENEPRESIDENT & CEOForm 4 sale7,308$404k26.8%RoutineSEC
Mar 10, 2026Mar 11, 2026XENEPRESIDENT & CEOForm 4 sale281,269$17M95.0%UnusualSEC
Jan 2, 2026Jan 2, 2026XENEOfficer, DirectorForm 144 notice40,000$1.8MNoticeSEC
Jan 2, 2026Jan 2, 2026XENEPRESIDENT & CEOForm 4 sale40,000$1.8M87.0%RoutineSEC
Dec 8, 2025Dec 9, 2025XENEPRESIDENT & CEOForm 4 sale25,205$1.1M80.8%RoutineSEC
Dec 8, 2025Dec 8, 2025XENEOfficer, DirectorForm 144 notice10,830$495kNoticeSEC
Dec 5, 2025Dec 5, 2025XENEOfficer, DirectorForm 144 notice14,375$647kNoticeSEC
Dec 1, 2025Dec 1, 2025XENEOfficer, DirectorForm 144 notice97$4kNoticeSEC
Nov 28, 2025Dec 3, 2025XENEPRESIDENT & CEOForm 4 sale97$4k0.3%RoutineSEC
Oct 1, 2025Oct 1, 2025XENEOfficer, DirectorForm 144 notice25,000$1MNoticeSEC
Oct 1, 2025Oct 1, 2025XENEPRESIDENT, CEO & INTERIM CFOForm 4 sale25,000$1M44.4%RoutineSEC
Jan 27, 2025Jan 27, 2025XENEOfficer, DirectorForm 144 notice16,315$661kNoticeSEC
Jan 27, 2025Jan 27, 2025XENEPRESIDENT & CEOForm 4 sale55,000$2.2M63.7%RoutineSEC
Jan 24, 2025Jan 24, 2025XENEOfficer, DirectorForm 144 notice22,468$903kNoticeSEC
Jan 23, 2025Jan 23, 2025XENEOfficer, DirectorForm 144 notice16,217$650kNoticeSEC
May 24, 2023May 26, 2023XENEPRESIDENT & CEOForm 4 sale31,655$1.3M50.3%UnusualSEC
May 24, 2023May 24, 2023XENEDirector, OfficerForm 144 notice31,655$1.3MNoticeSEC